Antibiotic resistant bacterial infections are treated using alternative drug combinations and novel therapies.
the verdict
SUPPORTED
the evidence backs this
confidence 75/100
Multiple studies demonstrate that antibiotic-resistant infections are actively managed and treated using novel drug combinations, such as antibiotic-adjuvant or phage-antibiotic therapies, alongside innovative alternative approaches.
Evidence for · 5
Mechanisms of colistin resistance and the antimicrobial effects of antibiotic and adjuvant combination on colistin-resistant Klebsiella pneumoniae
cited by 0
Paper [0] demonstrates that combining colistin with an EDTA adjuvant successfully treats resistant Klebsiella pneumoniae infections.
See more details
More for · 4
Phage-Antibiotic Combination Therapy for Antibiotic-Resistant Bacteria; Synergistic Mechanisms and Clinical Applications: A Systematic Review
2026 · cited by 0
Paper [1] provides a systematic review showing that phage-antibiotic combinations synergistically treat multidrug-resistant bacterial infections.
Synergistic enhancement effects of antibiotic combination with photodynamic inactivation
2022 · cited by 0
Paper [2] shows that combining photodynamic inactivation with antibiotics restores bacterial sensitivity and creates synergistic therapeutic effects.
Novel Strategies for Targeting Biofilm-Associated Bacterial Resistance
2026 · cited by 0
Paper [4] discusses multidisciplinary novel strategies, such as nanotechnology and smart delivery systems, to treat drug-resistant biofilm infections.
Novel Therapeutic Strategies for Staphylococcus aureus Biofilm Infections
cited by 0
Paper [5] highlights novel therapeutic strategies like nanomedicine and targeted radioimmunotherapy to overcome Staphylococcus aureus biofilm-associated resistance.